CSIMarket
 


Forty Seven Inc   (FTSV)
Other Ticker:  
 
 

FTSV's Income from Cont. Operations Growth by Quarter and Year

Forty Seven Inc 's Income from Cont. Operations results by quarter and year




FTSV Income from Cont. Operations (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December -26.24 38.38 0.00 0.00
III Quarter September -15.16 -21.66 0.00 0.00
II Quarter June -23.21 -16.72 0.00 0.00
I Quarter March -23.02 0.00 0.00 0.00
FY   -87.63 0.00 0.00 0.00



FTSV Income from Cont. Operations fourth quarter 2019 Y/Y Growth Comment
Forty Seven Inc in the fourth quarter 2019 recorded loss from continued operations of $ -26.24 millions.

According to the results reported in the fourth quarter 2019, Forty Seven Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Forty Seven Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the fourth quarter 2019.




FTSV Income from Cont. Operations ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Forty Seven Inc 's fourth quarter 2019 Income from Cont. Operations $ -26.24 millions FTSV's Income Statement
Forty Seven Inc 's fourth quarter 2018 Income from Cont. Operations $ 38.38 millions Quarterly FTSV's Income Statement
New: More FTSV's historic Income from Cont. Operations Growth >>


FTSV Income from Cont. Operations (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Forty Seven Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FTSV's IV. Quarter Q/Q Income from Cont. Operations Comment
Recent loss from continued operations of -26.24 millions by Forty Seven Inc appear even more unfavourable compare to the loss from continued operations -15.16 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Forty Seven Inc achieved highest sequential Income from Cont. Operations growth. While Forty Seven Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FTSV's IV. Quarter Q/Q Income from Cont. Operations Comment
Current loss from continued operations of -26.24 millions by Forty Seven Inc appear even less good considering the -15.16 millions loss from continued operations in the previous quarter.

Within Major Pharmaceutical Preparations industry Forty Seven Inc achieved highest sequential Income from Cont. Operations growth. While Forty Seven Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Forty Seven Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
Cumulative Income from Cont. Operations 12 Months Ending $ -87.62 $ -23.00 $ -29.50 $ -23.02 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Forty Seven Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -88 millions in the Dec 31 2019 period.
The business is getting worse as the cumulative loss from continued operations is getting bigger from $ -23 millions in TTM ending quarter Sep 30 2019 and $ millions for the twelve months ending in the quarter Dec 31 2018.

Forty Seven Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Forty Seven Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -88 millions in the Dec 31 2019 period.
The situation is getting worse as the cumulative loss from continued operations is getting bigger from $ -23 millions in the twelve months ending a quarter before and $ millions for the twelve months ending in the quarter Dec 31 2018.

Forty Seven Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
FTSV's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for FTSV's Competitors
Income from Cont. Operations Growth for Forty Seven Inc 's Suppliers
Income from Cont. Operations Growth for FTSV's Customers

You may also want to know
FTSV's Annual Growth Rates FTSV's Profitability Ratios FTSV's Asset Turnover Ratio FTSV's Dividend Growth
FTSV's Roe FTSV's Valuation Ratios FTSV's Financial Strength Ratios FTSV's Dividend Payout Ratio
FTSV's Roa FTSV's Inventory Turnover Ratio FTSV's Growth Rates FTSV's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2019
Universal Health Services Inc -0.39%$ -0.386 millions
Prestige Consumer Healthcare Inc -0.62%$ -0.618 millions
Zoetis Inc -3.03%$ -3.030 millions
Bruker Corporation-4.18%$ -4.178 millions
Conmed Corporation-4.59%$ -4.593 millions
Hill rom Holdings Inc -5.69%$ -5.687 millions
Quidelortho Corp-5.71%$ -5.705 millions
Novartis Ag-6.95%$ -6.953 millions
Catalent Inc -7.14%$ -7.143 millions
Akorn Inc-7.18%$ -7.182 millions
Pacific Health Care Organization Inc -10.95%$ -10.955 millions
Amgen Inc -11.67%$ -11.670 millions
U S Physical Therapy Inc-12.13%$ -12.126 millions
Fonar Corporation-13.47%$ -13.466 millions
Acorda Therapeutics Inc -18.93%$ -18.925 millions
Phibro Animal Health Corporation-19.35%$ -19.352 millions
United Therapeutics Corporation-19.45%$ -19.449 millions
Regeneron Pharmaceuticals Inc -19.47%$ -19.467 millions
Lantheus Holdings Inc -21.39%$ -21.387 millions
Lemaitre Vascular Inc -23.44%$ -23.436 millions
Antares Pharma Inc -23.46%$ -23.459 millions
National Healthcare Corp-24.53%$ -24.531 millions
Fresenius Medical Care Ag-27.61%$ -27.611 millions
3m Company-28.09%$ -28.095 millions
Ionis Pharmaceuticals Inc-32.63%$ -32.628 millions
Sanofi-35.67%$ -35.669 millions
Integra Lifesciences Holdings Corp-39.06%$ -39.060 millions
Alpha Pro Tech Ltd -44.72%$ -44.720 millions
Pediatrix Medical Group Inc -45.22%$ -45.224 millions
Icon Plc-45.31%$ -45.312 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com